News Focus
News Focus
icon url

I-Glow

03/02/19 6:39 PM

#162763 RE: Ping70 #162761

I have never seen a reverse split result in better financing.

OWCP is a empty shell without assets or revenue - the only option is toxic financing.

If their patent applications had any value there would be financiers Lining up to provide capital - just as they did for GWP - but the pharmaceutical investors understand the OWCP patent applications are worthless.

IG